TEMPLATE GECCO core (GECCO core)

TEMPLATE IDGECCO core
ConceptGECCO core
DescriptionTo support the systematic collection of scientific data on COVID-19 in Germany.
UseBasis of the data set are both the ISARIC protocol of the WHO as well as the data concepts of the LEOSS-Register. The purpose of ISARIC is to prevent disease and death from outbreaks of infectious diseases such as COVID-19. ISARIC brings together clinical research networks worldwide to provide the fastest possible research response to an outbreak of an infectious disease. The requirements used in the creation of this template are sourced from the FHIR IG - https://simplifier.net/guide/GermanCoronaConsensusDataSet-ImplementationGuide/Anticoagulation
PurposeTo support the systematic collection of scientific data on COVID-19 in Germany.
References
Authorsname: Heather Leslie; organisation: Atomica Informatics; email: heather.leslie@atomicainformatics.com; date: 2020-07-28
Other Details Languagename: Heather Leslie; organisation: Atomica Informatics; email: heather.leslie@atomicainformatics.com; date: 2020-07-28
Other Details (Language Independent)
  • MD5-CAM-1.0.1: 091994ba9d0365e8fdef60f775622b35
  • PARENT:MD5-CAM-1.0.1: 5CB5FECD224DABB2118F808E89A300CE
  • Original Language: ISO_639-1::en
Language useden
Citeable Identifier1013.26.372
Root archetype idopenEHR-EHR-COMPOSITION.data_set.v0
German Corona Consensus Data Set (GECCO)German Corona Consensus Data Set (GECCO): Generic composition to represent a data set for use in research
Anamnesis/Risk factorsAnamnesis/Risk factors: A generic section header which should be renamed in a template to suit a specific clinical context.
Chronic lung diseaseChronic lung disease: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Does the patient suffer from a chronic lung disease?Does the patient suffer from a chronic lung disease?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
Specific diseaseSpecific disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
  • Asthma
  • COPD
  • Fibrosis of lung
  • Pulmonary hypertension
  • Extreme obesity with alveolar hypoventilation
  • Sleep apnea
  • Obstructive sleep apnea syndrome
  • Cystic fibrosis
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Other diseaseOther disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Disorders of cardiovascular systemDisorders of cardiovascular system: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Does the patient suffer from a cardiovascular disease?Does the patient suffer from a cardiovascular disease?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
Specific diseaseSpecific disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
  • High blood pressure
  • History of myocardial infarction
  • Cardiac arrhythmia
  • Heart failure
  • Peripheral arterial occlusive disease
  • History of heart revascularization
  • Coronary arteriosclerosis
  • Carotid artery stenosis
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Other diseaseOther disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
CommentComment: Additional narrative about the conditions, not captured in other fields.
Rheumatological/immunological diseasesRheumatological/immunological diseases: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Does the patient suffer from at least one rheumatological or immunological disease?Does the patient suffer from at least one rheumatological or immunological disease?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
Specific diseaseSpecific disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
  • Inflammatory bowel disease
  • Rheumatic arteritis
  • Disorder of connective tissue
  • Vasculitis
  • Congenital immunodeficiency disease
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Other diseaseOther disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Human immunodeficiency virus infectionHuman immunodeficiency virus infection: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Is the patient infected with HIV?Is the patient infected with HIV?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
History of being a tissue or organ transplant recipientHistory of being a tissue or organ transplant recipient: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Does the patient have a history of being an organ transplant recipient?Does the patient have a history of being an organ transplant recipient?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
Specific transplantSpecific transplant: Grouping of data elements related to screening for a single condition.
Transplanted organ nameTransplanted organ name: Name of the condition being screened.
  • Heart transplant
  • Lung transplant
  • Liver transplant
  • Kidneys transplant
  • Intestine transplant
  • Skin transplant
  • Cornea transplant
  • Ossicle transplant
  • Heartvalve transplant
  • Blood vessel transplant
  • Cerebral meninges transplant
  • Bone tissue transplant
  • Cartilage tissue transplant
  • Tendon transplant
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Diabetes mellitusDiabetes mellitus: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Does the patient suffer from diabetes?Does the patient suffer from diabetes?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
Specific diseaseSpecific disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
  • Diabetes mellitus type 1
  • Diabetes mellitus type 2
  • Insulin treated type 2 diabetes mellitus
  • Secondary diabetes mellitus
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Malignant neoplastic diseasesMalignant neoplastic diseases: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Does the patient suffer from at least one active tumor or cancer disease?Does the patient suffer from at least one active tumor or cancer disease?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
Chronic neurological or mental diseasesChronic neurological or mental diseases: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Does the patient suffer from at least one chronic neurological disease or psychiatric illness? Which one?Does the patient suffer from at least one chronic neurological disease or psychiatric illness? Which one?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
Specific diseaseSpecific disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
  • Parkinson's disease
  • Dementia
  • Multiple sclerosis
  • Combined disorder of muscle and peripheral nerve
  • Epilepsy
  • Migraine
  • History of a cerebrovascular accident with residual deficit
  • History of a cerebrovascular accident without residual deficits
  • Psychotic disorder
  • Depressive disorder
  • Anxiety disorder
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Chronic kidney diseasesChronic kidney diseases: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Does the patient suffer from chronic kidney disease?Does the patient suffer from chronic kidney disease?: Presence of any relevant conditions.
  • Present 
  • Absent 
  • Unknown 
Specific diseaseSpecific disease: Grouping of data elements related to screening for a single condition.
Disease nameDisease name: Name of the condition being screened.
  • With hemodialysis
  • Without hemodialysis
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Gastrointestinal ulcersGastrointestinal ulcers: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Specific diseaseSpecific disease: Grouping of data elements related to screening for a single condition.
Condition nameCondition name: Name of the condition being screened.
  • Gastrointestinal ulcers
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Disease certaintyDisease certainty: Details about a single identified health condition, injury, disability or any other issue which impacts on the physical, mental and/or social well-being of an individual.
Clear delineation between the scope of a problem versus a diagnosis is not easy to achieve in practice. For the purposes of clinical documentation with this archetype, problem and diagnosis are regarded as a continuum, with increasing levels of detail and supportive evidence usually providing weight towards the label of 'diagnosis'.
Data
Problem/Diagnosis nameProblem/Diagnosis name: Identification of the problem or diagnosis, by name.
Coding of the name of the problem or diagnosis with a terminology is preferred, where possible.
  • Asthma
  • COPD
  • Fibrosis of lung
  • Pulmonary hypertension
  • Extreme obesity with alveolar hypoventilation
  • Sleep apnea
  • Obstructive sleep apnea syndrome
  • Cystic fibrosis
  • High blood pressure
  • History of myocardial infarction
  • Cardiac arrhythmia
  • Heart failure
  • Peripheral arterial occlusive disease
  • History of heart revascularization
  • Coronary arteriosclerosis
  • Carotid artery stenosis
  • Inflammatory bowel disease
  • Rheumatic arteritis
  • Disorder of connective tissue
  • Vasculitis
  • Congenital immunodeficiency disease
  • Heart transplant
  • Lung transplant
  • Liver transplant
  • Kidneys transplant
  • Intestine transplant
  • Skin transplant
  • Cornea transplant
  • Ossicle transplant
  • Heartvalve transplant
  • Blood vessel transplant
  • Cerebral meninges transplant
  • Bone tissue transplant
  • Cartilage tissue transplant
  • Tendon transplant
  • Diabetes mellitus type 1
  • Diabetes mellitus type 2
  • Insulin treated type 2 diabetes mellitus
  • Secondary diabetes mellitus
  • Malignant neoplastic disease
  • Parkinson's disease
  • Dementia
  • Multiple sclerosis
  • Combined disorder of muscle and peripheral nerve
  • Epilepsy
  • Migraine
  • Cerebrovascular accident with residual deficit
  • Cerebrovascular accident without residual deficits
  • Psychotic disorder
  • Depressive disorder
  • Anxiety disorder
  • Kidney disease with hemodialysis
  • Kidney disease without hemodialysis
  • Gastrointestinal ulcers
Diagnostic certaintyDiagnostic certainty: The level of confidence in the identification of the diagnosis.
  •  Coded Text
    • Suspected 
    • Probable 
    • Confirmed 
  •  Text
Protocol
Last updatedLast updated: The date this problem or diagnosis was last updated.
Disease exclusionDisease exclusion: A statement of exclusion of a specific Problem/diagnosis, Family history, Medication, Procedure, Adverse reaction or other clinical item that is either not currently present, or have not been present in the past.
Data
Problem/diagnosisProblem/diagnosis: The problem or diagnosis to which the 'Exclusion statement' applies. For example: 'Diabetes', 'COPD' or 'Asthma'.
  • Asthma
  • COPD
  • Fibrosis of lung
  • Pulmonary hypertension
  • Extreme obesity with alveolar hypoventilation
  • Sleep apnea
  • Obstructive sleep apnea syndrome
  • Cystic fibrosis
  • High blood pressure
  • History of myocardial infarction
  • Cardiac arrhythmia
  • Heart failure
  • Peripheral arterial occlusive disease
  • History of heart revascularization
  • Coronary arteriosclerosis
  • Carotid artery stenosis
  • Inflammatory bowel disease
  • Rheumatic arteritis
  • Disorder of connective tissue
  • Vasculitis
  • Congenital immunodeficiency disease
  • Heart transplant
  • Lung transplant
  • Liver transplant
  • Kidneys transplant
  • Intestine transplant
  • Skin transplant
  • Cornea transplant
  • Ossicle transplant
  • Heartvalve transplant
  • Blood vessel transplant
  • Cerebral meninges transplant
  • Bone tissue transplant
  • Cartilage tissue transplant
  • Tendon transplant
  • Diabetes mellitus type 1
  • Diabetes mellitus type 2
  • Insulin treated type 2 diabetes mellitus
  • Secondary diabetes mellitus
  • Malignant neoplastic disease
  • Parkinson's disease
  • Dementia
  • Multiple sclerosis
  • Combined disorder of muscle and peripheral nerve
  • Epilepsy
  • Migraine
  • Cerebrovascular accident with residual deficit
  • Cerebrovascular accident without residual deficits
  • Psychotic disorder
  • Depressive disorder
  • Anxiety disorder
  • Kidney disease with hemodialysis
  • Kidney disease without hemodialysis
  • Gastrointestinal ulcers
CommentComment: Additional narrative about the Specific Exclusion not captured in other fields.
Active malignant neoplastic diseaseActive malignant neoplastic disease: Details about a single identified health condition, injury, disability or any other issue which impacts on the physical, mental and/or social well-being of an individual.
Clear delineation between the scope of a problem versus a diagnosis is not easy to achieve in practice. For the purposes of clinical documentation with this archetype, problem and diagnosis are regarded as a continuum, with increasing levels of detail and supportive evidence usually providing weight towards the label of 'diagnosis'.
Data
Problem/Diagnosis nameProblem/Diagnosis name: Identification of the problem or diagnosis, by name.
Coding of the name of the problem or diagnosis with a terminology is preferred, where possible.
Problem/Diagnosis qualifierProblem/Diagnosis qualifier: Contextual or temporal qualifier for a specified problem or diagnosis.
Remission statusRemission status: Status of the remission of an incurable diagnosis.
For example: the status of a cancer or haematological diagnosis.
  • In remission 
  • Not in remission 
  • Indeterminate 
Protocol
Last updatedLast updated: The date this problem or diagnosis was last updated.
Travel eventTravel event: Details about a specific trip or travel event.
Data
Specific destinationSpecific destination: Details about a single location visited on a trip.
CountryCountry: The country visited.
State/regionState/region: The region visited.
Different regions within the same country maybe identified if they potentially pose different health risks.
CityCity: The city visited.
Different cities within the same country or region maybe identified if they potentially pose different health risks.
Travel start dateTravel start date: Date of entry to the identified location.
Travel end dateTravel end date: Date of exit from the identified location.
Tobacco smoking summaryTobacco smoking summary: Summary or persistent information about the tobacco smoking habits of an individual.
Data
Overall statusOverall status: Statement about current smoking behaviour for all types of tobacco.
  • Never smoked 
  • Current smoker 
  • Former smoker 
Overall commentOverall comment: Additional narrative about all tobacco smoking that has not been captured in other fields.
For example: stopped smoking or reduced amount on becoming pregnant.
  • Heavy tobacco smoker
  • Light tobacco smoker
  • Everyday smoker
  • Some day smoker
Respiratory therapiesRespiratory therapies: An individual- or self-reported questionnaire screening for management or treatment carried out.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Management/treatment activityManagement/treatment activity: Grouping of data elements related to screening for a single management or treatment activity.
Activity nameActivity name: Name of the management or treatment activity being screened.
  • Did oxygen or respiratory therapy already exist before the current illness?
PresencePresence: The current status of a specific activity.
  • Present 
  • Absent 
  • Unknown 
**Immunisation administration**Immunisation administration: Any activity related to the planning, scheduling, prescription management, dispensing, administration, cessation and other use of a medication, vaccine, nutritional product or other therapeutic item.
This is not limited to activities performed based on medication orders from clinicians, but could also include for example taking over the counter medication.
Description
Medication itemMedication item: Name of the medication, vaccine or other therapeutic/prescribable item which was the focus of the activity.
For example: 'Atenolol 100mg' or 'Tenormin tablets 100mg'. It is strongly recommended that the 'Medication item' is coded with a terminology capable of triggering decision support, where possible. The extent of coding may vary from the simple name of the medication item through to structured details about the actual medication pack used. Free text entry should only be used if there is no appropriate terminology available.
  • Influenza
  • Pneumococcal
  • BCG
  • COVID-19
Clinical indicationClinical indication: The clinical reason for the medication activity.
For example: 'Angina' or 'Pain'. Coding of the indication with a terminology is preferred, where possible. This data element allows multiple occurrences. If only an ACTION is used to record a medication indication, this data element can be used without additional consideration. However, if a clinical indication is recorded for both the Medication order INSTRUCTION and this Medication management ACTION, be aware that these indications might not be consistent."
Sequence numberSequence number: The sequence number specific to the pathway step being recorded.
For example: Vaccine sequence number.
**OR Immunization status**OR Immunization status: Summary of the immunisation status for an identified infectious disease or agent.
Data
Infectious disease or agentInfectious disease or agent: Identification of the infectious disease or agent.
There may be multiple diseases or agents that are vaccinated together - for example: diptheria, tetanus and pertussis or measles, mumps and rubella.
  • Influenza
  • Pneumococcal
  • BCG
  • COVID-19
Immunisation statusImmunisation status: An assertion about whether the immunisation course is up-to-date.
  • Immunisation up-to-date 
  • Immunisation not up-to-date 
Resuscitation statusResuscitation status: Anticipatory decisions about the overall intent of care and possible interventions (including treatments, activities, and diagnostic or therapeutic procedures), asserted by a clinician.
Data
CPR decisionCPR decision: Decision about the extent of cardiopulmonary resuscitation (CPR) intervention appropriate for this individual.
  • Full CPR 
  • No CPR 
  • Unknown 
ImagingImaging: A generic section header which should be renamed in a template to suit a specific clinical context.
Imaging examination resultImaging examination result: Record the findings and interpretation of an imaging examination performed.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Test nameTest name: The name of the imaging examination or procedure performed.
Coding with a terminology, potentially a pre-coordinated term specifying both modality and anatomical location, is desirable where possible. Possible candidate terminologies: LOINC, SNOMED CT or RadLex.
  • Lung CT
  • Lung radiography
  • Lung ultrasonography
Anatomical siteAnatomical site: Simple description about the physical place on, or in, the body that was imaged.
This data element is redundant if the anatomical site is identified in the 'Test name'.
Radiological findingsRadiological findings: Single word, phrase or brief description representing the likely condition or diagnosis.
This data element has multiple occurrences to allow for more than one diagnoses. Coding with a terminology is preferred, where possible. This data element should be regarded as mutually exclusive to 'Differential diagnoses' - only one of 'Differential diagnoses' OR 'Imaging diagnosis' should be present in the each Imaging examination result.
  • Undetermined finding
  • COVID-19-characteristic finding
  • Normal finding
DemographicsDemographics: A generic section header which should be renamed in a template to suit a specific clinical context.
PregnancyPregnancy: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Specific conditionSpecific condition: Grouping of data elements related to screening for a single condition.
Condition nameCondition name: Name of the condition being screened.
  • Pregnancy
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
GenderGender: Details about the gender of an individual.
Data
Sex at birthSex at birth: The sex of an individual determined by anatomical characteristics observed and registered at birth.
For example: 'Male', 'Female', 'Intersex'. Coding with a terminology is recommended, where possible. Use the element 'Comment' or the SLOT 'Details' if needed to register more specific details of the individuals gender.
Frailty scoreFrailty score: An assessment scale used to screen for frailty and to broadly stratify degrees of fitness and frailty in an older adult.
Also known as the Rockwood Clinical Frailty Scale.
Data
Any point in time eventAny point in time event: Default, unspecified point in time event which may be explicitly defined in a template or at run-time.
Data
AssessmentAssessment: Assessed level of frailty.
  • 1: Very Fit 
  • 2: Well 
  • 3: Managing Well 
  • 4: Vulnerable 
  • 5: Mildly Frail 
  • 6: Moderately Frail 
  • 7: Severely Frail 
  • 8: Very Severely Frail 
  • 9: Terminally Ill 
Body weightBody weight: Measurement of the body weight of an individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
WeightWeight: The weight of the individual.
0..1000; 0..2000; 0..1000000
Units:
  • kg
  • lbm
  • g
Body heightBody height: Height, or body length, is measured from crown of head to sole of foot.
Height is measured with the individual in a standing position and body length in a recumbent position.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Height/LengthHeight/Length: The length of the body from crown of head to sole of foot.
0..1000; 0..250
Units:
  • cm
  • in
Epidemiological factorsEpidemiological factors: A generic section header which should be renamed in a template to suit a specific clinical context.
Exposure screening questionnaireExposure screening questionnaire: A screening questionnaire about potential exposure to a chemical, physical or biological agent which has caused or may cause harm to an individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
AgentAgent: The name of the chemical, physical or biological agent to which an individual may have been exposed.
Coding of 'Agent' with a terminology is preferred, where possible. Free text should be used only if there is no appropriate terminology available. For example: 2019-nCoV; or HIV.
  • COVID-19
Specific exposureSpecific exposure: Details about each possible specific exposure circumstance.
Exposure situationExposure situation: The circumstance of possible exposure.
For example: Travel to an 'at risk' location; exposure to infected body fluids; or worked as a dental technician. Coding of 'Exposure situation' with a terminology is preferred, where possible.
  • Did the patient knowingly have contact with a person with probable or proven Covid-19 disease within 14 days before the onset of his/her symptoms?
PresencePresence: Presence of the exposure situation.
  • Present 
  • Absent 
  • Unknown 
ComplicationComplication: A generic section header which should be renamed in a template to suit a specific clinical context.
ComplicationComplication: An screeing questionnaire for conditions, including problems and diagnoses.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Thromboembolic eventsThromboembolic events: Grouping of data elements related to screening for a single condition.
Complication nameComplication name: Name of the condition being screened.
  • Venous thrombosis
  • Pulmonary embolism
  • Stroke
  • Myocardial infarction
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Infectious disease of lungInfectious disease of lung: Grouping of data elements related to screening for a single condition.
Complication nameComplication name: Name of the condition being screened.
  • Infectious disease of lung
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Infectious agent in blood streamInfectious agent in blood stream: Grouping of data elements related to screening for a single condition.
Complication nameComplication name: Name of the condition being screened.
  • Infectious agent in blood stream
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
OtherOther: Grouping of data elements related to screening for a single condition.
Complication nameComplication name: Name of the condition being screened.
Presence?Presence?: Presence of the condition.
  • Present 
  • Absent 
  • Unknown 
Onset of illness/AdmissionOnset of illness/Admission: A generic section header which should be renamed in a template to suit a specific clinical context.
Problem/DiagnosisProblem/Diagnosis: Details about a single identified health condition, injury, disability or any other issue which impacts on the physical, mental and/or social well-being of an individual.
Clear delineation between the scope of a problem versus a diagnosis is not easy to achieve in practice. For the purposes of clinical documentation with this archetype, problem and diagnosis are regarded as a continuum, with increasing levels of detail and supportive evidence usually providing weight towards the label of 'diagnosis'.
Data
Problem/Diagnosis nameProblem/Diagnosis name: Identification of the problem or diagnosis, by name.
Coding of the name of the problem or diagnosis with a terminology is preferred, where possible.
  • COVID-19
Stage at diagnosisStage at diagnosis: Additional narrative about the problem or diagnosis not captured in other fields.
  • Uncomplicated phase
  • Complicated phase
  • Critical phase
  • Recovery phase
  • Dead
Laboratory valuesLaboratory values: A generic section header which should be renamed in a template to suit a specific clinical context.
Laboratory valueLaboratory value: The result, including findings and the laboratory's interpretation, of an investigation performed on specimens collected from an individual or related to that individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Test nameTest name: Name of the laboratory investigation performed on the specimen(s).
A test result may be for a single analyte, or a group of items, including panel tests. It is strongly recommended that 'Test name' be coded with a terminology, for example LOINC or SNOMED CT. For example: 'Glucose', 'Urea and Electrolytes', 'Swab', 'Cortisol (am)', 'Potassium in perspiration' or 'Melanoma histopathology'. The name may sometimes include specimen type and patient state, for example 'Fasting blood glucose' or include other information, as 'Potassium (PNA blood gas)'.
  • CRP
  • Ferritin
  • Bilirubin
  • D-dimer
  • Gamma glutamyl transferase
  • Aspartate aminotransferase
  • Lactate dehydrogenase
  • Cardiac troponin
  • Hemoglobin
  • Creatinine
  • Lactate
  • Leukocytes
  • Lymphocytes
  • Neutrophils
  • Partial thromboplastin time
  • Platelets
  • INR
  • Albumin in serum
  • Antithrombin
  • Procalcitonin
  • Interleukin 6
  • Natriuretic peptide.B prohormone N-Terminal
  • Fibrinogen
Laboratory analyte resultLaboratory analyte result: The result of a laboratory test for a single analyte value.
Analyte nameAnalyte name: The name of the analyte result.
The value for this element is normally supplied in a specialisation, in a template or at run-time to reflect the actual analyte. For example: 'Serum sodium', 'Haemoglobin'. Coding with an external terminology is strongly recommended, such as LOINC, NPU, SNOMED CT, or local lab terminologies.
Optional[{fhir_mapping=Observation.code, hl7v2_mapping=OBX.3}]
  • CRP
  • Ferritin
  • Bilirubin
  • D-dimer
  • Gamma glutamyl transferase
  • Aspartate aminotransferase
  • Lactate dehydrogenase
  • Cardiac troponin
  • Hemoglobin
  • Creatinine
  • Lactate
  • Leukocytes
  • Lymphocytes
  • Neutrophils
  • Partial thromboplastin time
  • Platelets
  • INR
  • Albumin in serum
  • Antithrombin
  • Procalcitonin
  • Interleukin 6
  • Natriuretic peptide.B prohormone N-Terminal
  • Fibrinogen
SARS-CoV-2-RT-PCRSARS-CoV-2-RT-PCR: The result, including findings and the laboratory's interpretation, of an investigation performed on specimens collected from an individual or related to that individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Test nameTest name: Name of the laboratory investigation performed on the specimen(s).
A test result may be for a single analyte, or a group of items, including panel tests. It is strongly recommended that 'Test name' be coded with a terminology, for example LOINC or SNOMED CT. For example: 'Glucose', 'Urea and Electrolytes', 'Swab', 'Cortisol (am)', 'Potassium in perspiration' or 'Melanoma histopathology'. The name may sometimes include specimen type and patient state, for example 'Fasting blood glucose' or include other information, as 'Potassium (PNA blood gas)'.
  • SARS-CoV-2-RT-PCR
Laboratory analyte resultLaboratory analyte result: The result of a laboratory test for a single analyte value.
Analyte nameAnalyte name: The name of the analyte result.
The value for this element is normally supplied in a specialisation, in a template or at run-time to reflect the actual analyte. For example: 'Serum sodium', 'Haemoglobin'. Coding with an external terminology is strongly recommended, such as LOINC, NPU, SNOMED CT, or local lab terminologies.
Optional[{fhir_mapping=Observation.code, hl7v2_mapping=OBX.3}]
  • SARS-CoV-2-RT-PCR
SARS-CoV-2 antibodiesSARS-CoV-2 antibodies: The result, including findings and the laboratory's interpretation, of an investigation performed on specimens collected from an individual or related to that individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Test nameTest name: Name of the laboratory investigation performed on the specimen(s).
A test result may be for a single analyte, or a group of items, including panel tests. It is strongly recommended that 'Test name' be coded with a terminology, for example LOINC or SNOMED CT. For example: 'Glucose', 'Urea and Electrolytes', 'Swab', 'Cortisol (am)', 'Potassium in perspiration' or 'Melanoma histopathology'. The name may sometimes include specimen type and patient state, for example 'Fasting blood glucose' or include other information, as 'Potassium (PNA blood gas)'.
  • SARS-CoV-2 antibodies
Laboratory analyte resultLaboratory analyte result: The result of a laboratory test for a single analyte value.
Analyte nameAnalyte name: The name of the analyte result.
The value for this element is normally supplied in a specialisation, in a template or at run-time to reflect the actual analyte. For example: 'Serum sodium', 'Haemoglobin'. Coding with an external terminology is strongly recommended, such as LOINC, NPU, SNOMED CT, or local lab terminologies.
Optional[{fhir_mapping=Observation.code, hl7v2_mapping=OBX.3}]
  • SARS-CoV-2 IgG
  • SARS-CoV-2 IgM
MedicationMedication: A generic section header which should be renamed in a template to suit a specific clinical context.
COVID-19 therapyCOVID-19 therapy: An individual- or self-reported questionnaire screening for use of any medication or class of medication.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Screening purposeScreening purpose: The reason for overall screening.
For example: screening for previous use of a class lof medications, such as bisphosphonates.
Specific medicationSpecific medication: Details about the use of a specific medication.
Medication nameMedication name: Name of medication.
For example: Oxycodone.
  • Antipyretics
  • Corticosteroids
  • Atazanavir
  • Darunavir
  • Chloroquine phosphate
  • Hydroxychloroquine
  • Ivermectin
  • Lopinavir/ritonavir
  • Ganciclovir
  • Oseltamivir
  • Remdesivir
  • Ribavirin
  • Camostat
  • Favipiravir
  • Convalescent plasma
  • Steroids (> 0.5 mg/kg prednisone equivalents)
  • Steroids (<= 0.5 mg/kg prednisone equivalents)
  • Tocilizumab
  • Sarilumab
  • CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
  • Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
  • Il1-receptor antangonists
  • Ruxolitinib
  • Colchicine
  • Interferone (any)
  • 25-Hydroxyvitamin D
  • Zinc
Medication statusMedication status: Is the individual using the specific medication?
  •  Coded Text
    • Currently used 
    • Never used 
    • Used in the past 
    • Unknown 
  •  Text
CommentComment: Additional narrative about the medication use screening, not captured in other fields.
ACE inhibitorsACE inhibitors: An individual- or self-reported questionnaire screening for use of any medication or class of medication.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Screening purposeScreening purpose: The reason for overall screening.
For example: screening for previous use of a class lof medications, such as bisphosphonates.
Medication classMedication class: Details about the use of a specific class of medication.
Use another instance of this CLUSTER to represent a subclass of medication.
Class nameClass name: Name of class or subclass of medication.
For example: opioid drugs; or NSAIDs.
  • ACE inhibitors
Class statusClass status: Is the individual using the class of medication?
  •  Coded Text
    • Currently used 
    • Never used 
    • Used in the past 
    • Unknown 
  •  Text
Specific medicationSpecific medication: Details about the use of a specific medication.
Medication nameMedication name: Name of medication.
For example: Oxycodone.
  • ACE-HEMMER, REIN
  • ACE-Hemmer, rein
  • Captopril
  • Enalapril
  • Lisinopril
  • Perindopril
  • Ramipril
  • Quinapril
  • Benazepril
  • Cilazapril
  • Fosinopril
  • Trandolapril
  • Spirapril
  • Delapril
  • Moexipril
  • Temocapril
  • Zofenopril
  • Imidapril
  • ACE-HEMMER, KOMBINATIONEN
  • ACE-Hemmer und Diuretika
  • Captopril und Diuretika
  • Enalapril und Diuretika
  • Lisinopril und Diuretika
  • Perindopril und Diuretika
  • Ramipril und Diuretika
  • Quinapril und Diuretika
  • Benazepril und Diuretika
  • Cilazapril und Diuretika
  • Fosinopril und Diuretika
  • Delapril und Diuretika
  • Moexipril und Diuretika
  • Zofenopril und Diuretika
  • Captopril und Hydrochlorothiazid
  • Enalapril und Hydrochlorothiazid
  • Lisinopril und Hydrochlorothiazid
  • Ramipril und Hydrochlorothiazid
  • Quinapril und Hydrochlorothiazid
  • Benazepril und Hydrochlorothiazid
  • Cilazapril und Hydrochlorothiazid
  • Fosinopril und Hydrochlorothiazid
  • Moexipril und Hydrochlorothiazid
  • Zofenopril und Hydrochlorothiazid
  • Perindopril und Indapamid
  • Ramipril und Piretanid
  • ACE-Hemmer und Calciumkanalblocker
  • Enalapril und Lercanidipin
  • Lisinopril und Amlodipin
  • Perindopril und Amlodipin
  • Ramipril und Felodipin
  • Enalapril und Nitrendipin
  • Ramipril und Amlodipin
  • Trandolapril und Verapamil
  • Delapril und Manidipin
  • ACE-Hemmer, andere Kombinationen
  • Perindopril, Amlodipin und Indapamid
  • Perindopril und Bisoprolol
  • Ramipril, Amlodipin und Hydrochlorothiazid
  • Perindopril, Bisoprolol und Amlodipin
Medication statusMedication status: Is the individual using the specific medication?
  •  Coded Text
    • Currently used 
    • Never used 
    • Used in the past 
    • Unknown 
  •  Text
ImmunoglobulinsImmunoglobulins: An individual- or self-reported questionnaire screening for use of any medication or class of medication.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Screening purposeScreening purpose: The reason for overall screening.
For example: screening for previous use of a class lof medications, such as bisphosphonates.
Medication classMedication class: Details about the use of a specific class of medication.
Use another instance of this CLUSTER to represent a subclass of medication.
Class nameClass name: Name of class or subclass of medication.
For example: opioid drugs; or NSAIDs.
  • Immunoglobulins
Class statusClass status: Is the individual using the class of medication?
  •  Coded Text
    • Currently used 
    • Never used 
    • Used in the past 
    • Unknown 
  •  Text
Specific medicationSpecific medication: Details about the use of a specific medication.
Medication nameMedication name: Name of medication.
For example: Oxycodone.
  • IMMUNGLOBULINE
  • Immunglobuline, normal human
  • Immunglobuline, normal human, zur extravasalen Anwendung
  • Immunglobuline, normal human, zur intravasalen Anwendung
  • Spezifische Immunglobuline
  • Anti-D(rh)-Immunglobulin
  • Tetanus-Immunglobulin
  • Varicella/Zoster-Immunglobulin
  • Hepatitis-B-Immunglobulin
  • Tollwut-Immunglobulin
  • Röteln-Immunglobulin
  • Kuhpocken-Immunglobulin
  • Staphylococcus-Immunglobulin
  • Cytomegalievirus-Immunglobulin
  • Diphtherie-Immunglobulin
  • Hepatitis-A-Immunglobulin
  • FSME-Immunglobulin
  • Pertussis-Immunglobulin
  • Masern-Immunglobulin
  • Mumps-Immunglobulin
  • Palivizumab
  • Motavizumab
  • Raxibacumab
  • Anthrax-Immunglobulin
  • Bezlotoxumab
  • Obiltoxaximab
  • Kombinationen
  • Andere Immunglobuline
  • Nebacumab
  • Andere Immunglobuline
Medication statusMedication status: Is the individual using the specific medication?
  •  Coded Text
    • Currently used 
    • Never used 
    • Used in the past 
    • Unknown 
  •  Text
AnticoagulationAnticoagulation: An individual- or self-reported questionnaire screening for use of any medication or class of medication.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Screening purposeScreening purpose: The reason for overall screening.
For example: screening for previous use of a class lof medications, such as bisphosphonates.
Specific medicationSpecific medication: Details about the use of a specific medication.
Medication nameMedication name: Name of medication.
For example: Oxycodone.
  • Unfractionated heparin
  • Low molecular weight heparin
  • Argatroban
  • Platelet aggregation inhibitor
  • Danaparoid
  • Phenprocoumon
  • Direct oral anticoagulants
Medication statusMedication status: Is the individual using the specific medication?
  •  Coded Text
    • Currently used 
    • Never used 
    • Used in the past 
    • Unknown 
  •  Text
Other (Thrombosis prophylaxis/Therapeutic anticoagulation)Other (Thrombosis prophylaxis/Therapeutic anticoagulation): Details about the use of a specific medication.
Medication nameMedication name: Name of medication.
For example: Oxycodone.
Medication statusMedication status: Is the individual using the specific medication?
  •  Coded Text
    • Currently used 
    • Never used 
    • Used in the past 
    • Unknown 
  •  Text
Outcome at dischargeOutcome at discharge: A generic section header which should be renamed in a template to suit a specific clinical context.
Episode of care - institutionEpisode of care - institution: Administrative details about a period of admitted patient care between a formal or statistical admission and a formal or statistical separation, characterised by only one care type of care from a healthcare institution.
Data
Respiratory outcomeRespiratory outcome: Outcome for the individual at the end of the episode.
For example: recovered/not recovered/death.
  • On ventilator
  • Not on ventilator
Type of dischargeType of discharge: The category of destination after discharge.
For example: home; hospital; nursing home; or rehabilitation hospital.
  • Alive
  • Admission to hospital
  • Referral to other institution
  • Death
  • Palliative discharge
  • Unknown
Follow-up swab resultFollow-up swab result: The result, including findings and the laboratory's interpretation, of an investigation performed on specimens collected from an individual or related to that individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Test nameTest name: Name of the laboratory investigation performed on the specimen(s).
A test result may be for a single analyte, or a group of items, including panel tests. It is strongly recommended that 'Test name' be coded with a terminology, for example LOINC or SNOMED CT. For example: 'Glucose', 'Urea and Electrolytes', 'Swab', 'Cortisol (am)', 'Potassium in perspiration' or 'Melanoma histopathology'. The name may sometimes include specimen type and patient state, for example 'Fasting blood glucose' or include other information, as 'Potassium (PNA blood gas)'.
  • SARS-CoV-2-RT-PCR
CommentComment: Additional narrative about the test result not captured in other fields.
Study enrollment/Inclusion criteriaStudy enrollment/Inclusion criteria: A generic section header which should be renamed in a template to suit a specific clinical context.
SymptomsSymptoms: A generic section header which should be renamed in a template to suit a specific clinical context.
Symptom/sign screening questionnaireSymptom/sign screening questionnaire: An individual- or self-reported questionnaire screening for symptoms and signs.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Presence of any symptoms or signs?Presence of any symptoms or signs?: Presence of any relevant symptoms or signs.
  • Present 
  • Absent 
  • Unknown 
Specific symptom/signSpecific symptom/sign: Grouping of data elements related to screening for a single symptom or sign.
Symptom or sign nameSymptom or sign name: Name of the symptom or sign being screened.
  • Loss of taste or smell
  • Abdominal pain
  • Clouded consciousness
  • Diarrhea
  • Vomiting
  • Cough
  • Dyspnea
  • Nausea
  • Fever
  • Headache
Presence?Presence?: Presence of the symptom or sign.
  • Present 
  • Absent 
  • Unknown 
Symptom/SignSymptom/Sign: Reported observation of a physical or mental disturbance in an individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Symptom/Sign nameSymptom/Sign name: The name of the reported symptom or sign.
Symptom name should be coded with a terminology, where possible.
  • Loss of taste or smell
  • Abdominal pain
  • Clouded consciousness
  • Diarrhea
  • Vomiting
  • Cough
  • Dyspnea
  • Nausea
  • Fever
  • Headache
Severity categorySeverity category: Category representing the overall severity of the symptom or sign.
Defining values such as mild, moderate or severe in such a way that is applicable to multiple symptoms or signs plus allows multiple users to interpret and record them consistently is not easy. Some organisations extend the value set further with inclusion of additional values such as 'Trivial' and 'Very severe', and/or 'Mild-Moderate' and 'Moderate-Severe', adds to the definitional difficulty and may also worsen inter-recorder reliability issues. Use of 'Life-threatening' and 'Fatal' is also often considered as part of this value set, although from a pure point of view it may actually reflect an outcome rather than a severity. In view of the above, keeping to a well-defined but smaller list is preferred and so the mild/moderate/severe value set is offered, however the choice of other text allows for other value sets to be included at this data element in a template. Note: more specific grading of severity can be recorded using the 'Specific details' SLOT.
  • Mild
  • Moderate
  • Severe
  • Life threatening
TherapyTherapy: A generic section header which should be renamed in a template to suit a specific clinical context.
Management/treatmentManagement/treatment: An individual- or self-reported questionnaire screening for management or treatment carried out.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Management/treatment activityManagement/treatment activity: Grouping of data elements related to screening for a single management or treatment activity.
Activity nameActivity name: Name of the management or treatment activity being screened.
  • Dialysis/hemofiltration
  • Apheresis
  • Prone position
  • ECMO therapy
  • Intensive care unit admission
PresencePresence: The current status of a specific activity.
  • Present 
  • Absent 
  • Unknown 
Ventilation typeVentilation type: An individual- or self-reported questionnaire screening for management or treatment carried out.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Management/treatment activityManagement/treatment activity: Grouping of data elements related to screening for a single management or treatment activity.
Ventilation typeVentilation type: Name of the management or treatment activity being screened.
  • Nasal High-Flow-Oxygen-Therapy
  • Non-invasive ventilation
  • Invasive ventilation (orotracheal)
  • Invasive ventilation (Tracheotomy)
PresencePresence: The current status of a specific activity.
  • Present 
  • Absent 
  • Unknown 
Vital signsVital signs: A generic section header which should be renamed in a template to suit a specific clinical context.
Blood gas analysisBlood gas analysis: The result, including findings and the laboratory's interpretation, of an investigation performed on specimens collected from an individual or related to that individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Test nameTest name: Name of the laboratory investigation performed on the specimen(s).
A test result may be for a single analyte, or a group of items, including panel tests. It is strongly recommended that 'Test name' be coded with a terminology, for example LOINC or SNOMED CT. For example: 'Glucose', 'Urea and Electrolytes', 'Swab', 'Cortisol (am)', 'Potassium in perspiration' or 'Melanoma histopathology'. The name may sometimes include specimen type and patient state, for example 'Fasting blood glucose' or include other information, as 'Potassium (PNA blood gas)'.
  • Blood gas analysis
Laboratory analyte resultLaboratory analyte result: The result of a laboratory test for a single analyte value.
Analyte nameAnalyte name: The name of the analyte result.
The value for this element is normally supplied in a specialisation, in a template or at run-time to reflect the actual analyte. For example: 'Serum sodium', 'Haemoglobin'. Coding with an external terminology is strongly recommended, such as LOINC, NPU, SNOMED CT, or local lab terminologies.
Optional[{fhir_mapping=Observation.code, hl7v2_mapping=OBX.3}]
  • PaCO2
  • PaO2
  • pH
State
Inspired oxygenInspired oxygen: The amount of oxygen being delivered, or to be delivered, to the patient given as a fraction, percentage or indirectly as a flow rate.
FiO₂FiO₂: Fraction of oxygen in inspired air.
For example: '0.28'.
  • Unitary
SOFA scoreSOFA score: A scoring system to grade and follow the development of organ dysfunction in six vital organ systems. Previously known as "Sepsis related Organ Failure Assessment".
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Cardiovascular systemCardiovascular system: The mean arterial pressure (MAP), or the need for vasopressors (VP), (dopamine (DA), adrenaline (A), noradrenaline (NA) or dobutamine) are indicators for a possible dysfunction of the cardiovascular system.
  • 0: MAP ≥ 70 mmHg 
  • 1: MAP < 70 mmHg 
  • 2: DA ≤ 5; Dobutamine 
  • 3: DA > 5; NA/A ≤ 0.1 
  • 4: NA/A > 0.1 
Central nervous systemCentral nervous system: The Glasgow Coma Scale (GCS) is an indicator for a possible dysfunction of the central nervous system.
  • 0: GCS 15 
  • 1: GCS 13 - 14 
  • 2: GCS 10 - 12 
  • 3: GCS 6 - 9 
  • 4: GCS < 6 
Renal functionRenal function: Creatinine concentration and 24 h urine output (UOP) are indicators for a possible dysfunction of the central nervous system.
In some localities, creatinine concentration is measured in μmol/L.
  • 0: Creatinine < 1.2 mg/dL 
  • 1: Creatinine 1.2-1.9 mg/dL 
  • 2: Creatinine 2.0-3.4 mg/dL 
  • 3: Creatinine 3.5-4.9 mg/dL or UOP < 500 mL/24h 
  • 4: Creatinine ≥ 5.0 mg/dL or UOP < 200 mL/24h 
Liver functionLiver function: Bilirubin concentration is an indicator for a possible dysfunction of the central nervous system.
In some localities, bilirubin concentration is measured in μmol/L.
  • 0: Bilirubin < 1.2 mg/dL 
  • 1: Bilirubin 1.2-1.9 mg/dL 
  • 2: Bilirubin 2.0-5.9 mg/dL 
  • 3: Bilirubin 6.0-11.9 mg/dL 
  • 4: Bilirubin ≥ 12.0 mg/dL 
Blood clottingBlood clotting: Platelets concentration is an indicator for a possible dysfunction of the blood clotting system.
  • 0: Platelets ≥ 150 (x10³/µL) 
  • 1: Platelets < 150 (x10³/µL) 
  • 2: Platelets < 100 (x10³/µL) 
  • 3: Platelets < 50 (x10³/µL) 
  • 4: Platelets < 20 (x10³/µL) 
Total scoreTotal score: The total sum of each component parameter for the SOFA score.
0..24
RespirationRespiration: The characteristics of spontaneous breathing by an individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Respiratory rateRespiratory rate: The frequency of spontaneous breathing.
0..200 /min
Blood pressureBlood pressure: The local measurement of arterial blood pressure which is a surrogate for arterial pressure in the systemic circulation.
Most commonly, use of the term 'blood pressure' refers to measurement of brachial artery pressure in the upper arm.
DataData: History Structural node.
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
SystolicSystolic: Peak systemic arterial blood pressure - measured in systolic or contraction phase of the heart cycle.
0..1000 mmHg
DiastolicDiastolic: Minimum systemic arterial blood pressure - measured in the diastolic or relaxation phase of the heart cycle.
0..1000 mmHg
Pulse/Heart beatPulse/Heart beat: The rate and associated attributes for a pulse or heart beat.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Heart rateHeart rate: The rate of the pulse or heart beat, measured in beats per minute.
0..1000 /min
Body temperatureBody temperature: A measurement of the body temperature, which is a surrogate for the core body temperature of the individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
TemperatureTemperature: The measured temperature.
0..100; 30..200
Units:
  • °C
  • °F
Peripheral oxygen saturationPeripheral oxygen saturation: Blood oxygen and related measurements, measured by pulse oximetry or pulse CO-oximetry.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
SpO₂SpO₂: The saturation of oxygen in the peripheral blood, measured via pulse oximetry.
SpO₂ is defined as the percentage of oxyhaemoglobin (HbO₂) to the total concentration of haemoglobin (HbO₂ + deoxyhaemoglobin) in peripheral blood.
  • Percent